M. Planker
Impact in
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Viral-associated cancers and disorders
Papers in
-
- Lymphoma Diagnosis and Treatment 7
- Genetics 4
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Harry BleibergJ. WilsU. VanhoeferH. BodensteinBernard NordlingerPhilippe RougierB PaillotH. Wilke
- Journals
- Journal of Clinical Oncology (3 papers)Blood (3 papers)Cancer (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- GermanyAustraliaSwitzerland
In The Last Decade
M. Planker
15 papers receiving 685 citations
Peers
Comparison fields: 5 of 49
- Gastroenterology 143
- Oncology 475
- Pulmonary and Respiratory Medicine 432
- Pathology and Forensic Medicine 163
- Genetics 68
Countries citing papers authored by M. Planker
This map shows the geographic impact of M. Planker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Planker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Planker more than expected).
Fields of papers citing papers by M. Planker
This network shows the impact of papers produced by M. Planker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Planker. The network helps show where M. Planker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Planker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2012 | 22 | |
| 3 | 2012 | 68 | |
| 4 | 2008 | 14 | |
| 5 | 2006 | 20 | |
| 6 | 2005 | 6 | |
| 7 | 2004 | 20 | |
| 8 | 2000 | 443 | |
| 9 | 1996 | 15 | |
| 10 | 1992 | 15 | |
| 11 | Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM). | 1990 | 26 |
| 12 | High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia. | 1987 | 36 |
| 13 | 1987 | 2 | |
| 14 | 1986 | 1 | |
| 15 | Synchronous double primary malignant lymphoma of low grade malignancy and early cancer (collision tumor) of the stomach. | 1984 | 24 |
| 16 | 1983 | 2 |
About M. Planker
M. Planker is a scholar working on Pathology and Forensic Medicine, Genetics, Gastroenterology, Hematology and Dermatology, having authored 16 papers that have together received 714 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (4 papers), Viral-associated cancers and disorders (3 papers), Acute Myeloid Leukemia Research (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Cutaneous lymphoproliferative disorders research (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Gastroesophageal reflux and treatments (1 paper). The work is most often cited by research in Gastroenterology (143 citations), Oncology (475 citations), Pulmonary and Respiratory Medicine (432 citations), Pathology and Forensic Medicine (163 citations) and Genetics (68 citations). M. Planker has collaborated with scholars based in Germany, Australia and Switzerland. Frequent co-authors include Harry Bleiberg, J. Wils, U. Vanhoefer, H. Bodenstein, Bernard Nordlinger, Philippe Rougier, B Paillot, H. Wilke, Pascal Piedbois and Benoît Baron. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer, Journal of Cancer Research and Clinical Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.